These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 2451375
21. PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis. Coven TR, Walters IB, Cardinale I, Krueger JG. Photodermatol Photoimmunol Photomed; 1999 Feb; 15(1):22-7. PubMed ID: 9990665 [Abstract] [Full Text] [Related]
22. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy. Staberg B, Hueg B. Acta Derm Venereol; 1985 Feb; 65(6):553-5. PubMed ID: 2420126 [Abstract] [Full Text] [Related]
23. [Treatment of plaque-type psoriasis with cream-PUVA therapy]. Steinmeyer K, Grundmann-Kollmann M, Podda M, Kaufmann R. Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819 [Abstract] [Full Text] [Related]
24. [Influence of retinoids on the bioavailability of methoxy-8-psoralen]. Beani JC, Bonnot D, Berthod F, Boitard M, Reymond JL, Beriel H, Amblard P. Ann Dermatol Venereol; 1991 Oct; 118(4):273-5. PubMed ID: 2069337 [Abstract] [Full Text] [Related]
25. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides. Wackernagel A, Hofer A, Legat F, Kerl H, Wolf P. Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785 [Abstract] [Full Text] [Related]
26. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses. Engin B, Oguz O. Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091 [Abstract] [Full Text] [Related]
27. Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation. Thune P, Volden G. Acta Derm Venereol; 1977 Apr; 57(4):351-5. PubMed ID: 70930 [Abstract] [Full Text] [Related]
28. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. Tanew A, Ortel B, Rappersberger K, Hönigsmann H. J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089 [Abstract] [Full Text] [Related]
29. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema. De Rie MA, Van Eendenburg JP, Versnick AC, Stolk LM, Bos JD, Westerhof W. Br J Dermatol; 1995 Jun; 132(6):964-9. PubMed ID: 7662576 [Abstract] [Full Text] [Related]
30. Shower PUVA: a novel variant of photochemotherapy. Distribution of photosensitivity and accumulation of trioxsalen in the skin. Sánchez Ruderisch H, Aryee-Boi J, Schwarz C, Radenhausen M, Tebbe B. Skin Pharmacol Physiol; 2004 Jun; 17(3):129-32. PubMed ID: 15087592 [Abstract] [Full Text] [Related]
31. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA. Legat FJ, Hofer A, Quehenberger F, Kahofer P, Kerl H, Wolf P. J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353 [Abstract] [Full Text] [Related]
32. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema. Cox NH, Farr PM, Diffey BL. Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859 [Abstract] [Full Text] [Related]